Skip to content
Application 216120
- Type
- ANDA
- Sponsor
- AM REGENT
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | ATROPINE SULFATE | ATROPINE SULFATE | SOLUTION;INTRAVENOUS | 0.4MG/ML (0.4MG/ML) | No | No |
| 002 | ATROPINE SULFATE | ATROPINE SULFATE | SOLUTION;INTRAVENOUS | 1MG/ML (1MG/ML) | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0517-1001 | Atropine Sulfate | ATROPINE SULFATE | American Regent, Inc. | ANDA | Current |
| 0517-1001 | Atropine Sulfate | ATROPINE SULFATE | American Regent, Inc. | ANDA | Current |
| 0517-1001 | Atropine Sulfate | ATROPINE SULFATE | American Regent, Inc. | ANDA | Current |
| 0517-1004 | Atropine Sulfate | ATROPINE SULFATE | American Regent, Inc. | ANDA | Current |
| 0517-1004 | Atropine Sulfate | ATROPINE SULFATE | American Regent, Inc. | ANDA | Current |
| 0517-1004 | Atropine Sulfate | ATROPINE SULFATE | American Regent, Inc. | ANDA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 71877 | ORIG | 2022-08-25 |